Bluemed Scientific Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -99.36%
- Profit Growth -601.55%
- Ebitda -140.36%
- Net Worth -8280.42%
- Total Assets -25.99%
About Bluemed Scientific
Bluemed Scientific Private Limited (BSPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 March 2012 and has a history of 12 years and 11 months. Its registered office is in East Delhi, Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Kumar and Neeru Thakur serve as directors at the Company.
Company Details
- Location
East Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U74900DL2012PTC232784
- Company No.
232784
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Bluemed Scientific Private Limited offer?
Bluemed Scientific Private Limited offers a wide range of products and services, including Forceps & Graspers, Endoscopy Instruments, Endoscopy & Laparoscopy instruments, Orthopedic Equipment & Supplies, Arthroscopic Instruments, Laparoscopic Instruments.
Who are the key members and board of directors at Bluemed Scientific?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Kumar  | Director | 13-Mar-2012 | Current |
| Neeru Thakur | Director | 13-Mar-2012 | Current |
Financial Performance of Bluemed Scientific.
Bluemed Scientific Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.36% decrease. The company also saw a substantial fall in profitability, with a 601.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 8280.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bluemed Scientific?
Unlock access to Bluemed Scientific's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bluemed Scientific?
Unlock and access historical data on people associated with Bluemed Scientific, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bluemed Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bluemed Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.